|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.165 EUR | 0.00% |
|
+1.75% | -20.75% |
| 06-29 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
| 06-22 | Erfo Keeps Buying Back Stock, Repurchases 28,000 Shares | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 3.95M | 4.74M | 4.62M | 7.86M |
Direct | 598K | 500K | 703K | 850K | 1.09M |
Other | - | 457K | 576K | 562K | 672K |
Medical | - | 125K | 244K | 306K | 411K |
Revenues from Services | 1.12K | - | - | - | - |
Wholesale Sales Revenues | 4.07M | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 4.66M | 5.01M | 5.23M | 5.33M | 8.96M |
France | - | - | 797K | 852K | 898K |
Belgium | - | - | 228K | 157K | 176K |
Other (EU) | - | - | 5K | - | - |
Spain | 8K | 15.4K | 5.17K | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 31/12/2012 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 31/12/2012 |
Flavio Corpina
BRD | Director/Board Member | 47 | 31/12/2016 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +1.75% | -12.41% | +6.88% | 11.36M | ||
| +1.86% | +7.65% | +55.77% | +158.84% | 1,082B | ||
| +3.57% | +7.42% | +69.09% | +58.92% | 633B | ||
| +3.99% | +7.37% | +36.87% | +93.77% | 461B | ||
| -1.20% | -1.94% | +26.41% | +20.22% | 339B | ||
| +4.94% | +3.39% | +39.92% | +28.93% | 301B | ||
| +2.42% | +1.60% | +30.06% | +42.24% | 292B | ||
| +2.47% | +5.18% | -24.80% | -39.60% | 225B | ||
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | ||
| +4.21% | +6.00% | +17.72% | +70.33% | 163B | ||
| Average | +2.11% | +4.24% | +26.47% | +50.90% | 369.97B | |
| Weighted average by Cap. | +1.86% | +5.21% | +41.48% | +80.22% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















